Chester County News and Community Website
EXTON, PA — Clayton Pharmaceuticals announced that they recently received FDA approval for Sucralfate Oral Suspension with Competitive Generic Therapy (CGT) designation.
Clayton Pharmaceuticals and VistaPharm Receive FDA Approval for Sucralfate Oral Suspension Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved the first generic of Restasis (cyclosporine ophthalmic emulsion) 0.05% single-use vials (eye drops) to increase tear production in patients …
FDA Approves First Generic of Restasis Read More
PHILADELPHIA, PA — Acting U.S. Attorney Jennifer Arbittier Williams announced that three generic pharmaceutical manufacturers, Taro Pharmaceuticals U.S.A., Inc., Sandoz Inc., and Apotex Corporation, this week agreed to pay a …
Pharmaceutical Companies Agree to Pay Almost Half a Billion Dollars to Resolve Alleged False Claims Act Liability Read More
WASHINGTON, D.C. — The following quote is attributed to Sally Choe, Ph.D., director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research:
FDA Reaches Milestone in Competitive Generic Therapy Drug Approvals Read More